Л.Саямаа
Loading...
Товч нэр
Л.Саямаа
Бүтэн нэр
Лхагвадорж Саямаа
Латин нэр
Lkhagvadorj Sayamaa
Албан тушаал
Тэнхимийн эрхлэгч
Эрдмийн цол
Дэд профессор
Боловсролын зэрэг
Доктор (Ph.D)
Харьяалал
ORCID
Scopus Author ID
9 results
Now showing 1 - 9 of 9
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Application of Galectin-3, HBME-1, Cytokeratin-19, and CD56 in the Diagnosis of Thyroid Neoplasm(Mongolian National University of Medical Sciences, 2019-06-25); ; ; ;Nyamjargal BaatarjalbuuAnarkhuu Bold-ErdeneObjective: The purpose of this study was to investigate the effectiveness of immunohistochemical thyroid malignancy markers Galectin-3, HBME-1, Cytokeratin-19, and CD56 in the diagnosis of thyroid neoplasm. Methods: The study included a total of 53 cases of thyroid neoplasm on which immunohistochemical IHC staining was performed using the manual staining method. Results: The histopathological diagnosis of thyroid nodules was papillary thyroid carcinoma in 40 (75.5%), follicular thyroid carcinoma in 3 (5.7%), follicular adenoma in 8 (15.1%), medullary thyroid carcinoma in 1 (1.9%), and Hurthle cell carcinoma in 1 (1.9%). Out of 40 cases of papillary thyroid carcinoma, Galectin-3 and CK19 were positive in 36 (90%) cases while expression of HBME1 was seen in 32 (80%) papillary thyroid carcinoma cases, and 16 (40%) stained positive for CD56. For the three follicular thyroid carcinoma cases, CD56 was positive in one case, but the marker was positive in 7 out of 8 cases (87.5%) of follicular adenoma. Conclusion: Our results suggest Galectin-3 and HBME-1 are the most sensitive diagnostic markers for differentiating papillary carcinoma from follicular neoplasm. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Sclerosing Angiomatoid Nodular Transformation of the Spleen: A Case Report(Mongolian National University of Medical Sciences, 2019-09-25); ; ; Objectives: Sclerosing Angiomatoid Nodular Transformation (SANT) of the spleen is a rare benign vascular lesion with unknown etiology. Our purpose is to present our experience with this condition and review the available literature regarding it. Methods: This report depicts a pathologically proven case of SANT in a 32-year-old man with a history of two previous old injuries who presented with weight loss, vomiting and with left upper quadrant pain and an enlarged spleen. Results: The patient was successfully treated by splenectomy and diagnosed with SANT based on histological and immunohistochemical findings postoperatively. Conclusion: Most patients with SANT are asymptomatic. Imaging studies are essential for detection and the management of SANT. However, the final diagnosis can only be made by histopathology. SANT does not recur after splenectomy. - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Orai1 and STIM1 are critical for cell migration and proliferation of clear cell renal cell carcinoma(Elsevier BV, 2014-05) ;Kim, Ji-Hee; ;Lee, Mi-Ra ;Hwang, Kyu-HeeChung, Hyun ChulScopus© Citations 95 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, HDAC1 Expression in Invasive Ductal Carcinoma of the Breast and Its Value as a Good Prognostic Factor(The Korean Society of Pathologists and The Korean Society for Cytopathology, 2012) ;Eom, Minseob ;Oh, Sung Soo; ;Han, AiriPark, Kwang HwaScopus© Citations 11 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Orai1 Expression Is Closely Related with Favorable Prognostic Factors in Clear Cell Renal Cell CarcinomaStore-operated calcium (Ca(2+)) entry (SOCE) is the principal Ca(2+) entry route in non-excitable cells, including cancer cells. We previously demonstrated that Orai1 and STIM1, the molecular components of SOCE, are involved in tumorigenesis of clear cell renal cell carcinoma (CCRCC). However, a clinical relevance of Orai1 and STIM1 expression in CCRCC has been ill-defined. Here, we investigated the expression of Orai1 and STIM1 in CCRCC, and compared their expression with clinico-pathological parameters of CCRCC and the patients' outcome. Immunohistochemical staining for Orai1 and STIM1 was performed on 126 formalin fixed paraffin embedded tissue of CCRCC and western blot analysis for Orai1 was performed on the available fresh tissue. The results were compared with generally well-established clinicopathologic prognostic factors in CCRCC and patient survival. Membrane protein Orai1 is expressed in the nuclei in CCRCC, whereas STIM1 shows the cytosolic expression pattern in immunohistochemical staining. Orai1 expression level is inversely correlated with CCRCC tumor grade, whereas STIM1 expression level is not associated with tumor grade. The higher Orai1 expression is significantly associated with lower Fuhrman nuclear grade, pathologic T stage, and TNM stage and with favorable prognosis. The expression level of STIM1 is not correlated with CCRCC grade and clinical outcomes. Orai1 expression in CCRCC is associated with tumor progression and with favorable prognostic factors. These results suggest that Orai1 is an attractive prognostic marker and therapeutic target for CCRCC.Scopus© Citations 5 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Scopus© Citations 13 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, ROS1 Expression in Invasive Ductal Carcinoma of the Breast Related to Proliferation Activity(Yonsei University College of Medicine, 2013) ;Eom, Minseob; ;Oh, Sung Soo ;Han, AiriPark, Kwang HwaScopus© Citations 16 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Klotho plays a critical role in clear cell renal cell carcinoma progression and clinical outcome(The Korean Physiological Society and The Korean Society of Pharmacology, 2016) ;Kim, Ji-Hee ;Hwang, Kyu-Hee; ;Jung, Jae HungChung, Hyun ChulScopus© Citations 11 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, DNA methylation status of a distinctively different subset of genes is associated with each histologic Lauren classification subtype in early gastric carcinogenesis(Spandidos Publications, 2014-06) ;Chong, Yosep ;Mia-Jan, Khalilullah ;Ryu, Hoon ;Abdul-Ghafar, JamshidMunkhdelger, JijgeeScopus© Citations 33
